Pathway CH-1 Long-Term Follow-Up
NCT01616511 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33
Last updated 2017-01-09
Summary
The objective of the study is to demonstrate the long-term safety and performance of the ATI Neurostimulation System when used for stimulation of the sphenopalatine ganglion (SPG) in cluster headache subjects.
Conditions
- Chronic Cluster Headache
Sponsors & Collaborators
-
Autonomic Technologies, Inc.
lead INDUSTRY
Principal Investigators
-
Jean Schoenen, MD, PhD · Citadelle Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-06-30
- Primary Completion
- 2016-06-30
- Completion
- 2016-06-30
Countries
- Belgium
- Denmark
- Spain
Study Locations
More Related Trials
-
SPG Neurostimulation in Cluster Patients
NCT02510729 ·Status: COMPLETED ·Phase: NA
-
Occipital Nerve Stimulation in Medically Intractable Chronic Cluster Headache
NCT01151631 ·Status: COMPLETED ·Phase: PHASE3
-
Eptinezumab in Participants With Episodic Cluster Headache
NCT04688775 ·Status: COMPLETED ·Phase: PHASE3
-
Bilateral Occipital Nerve Field Stimulation for the Treatment of dtCCH
NCT06124534 ·Status: SUSPENDED ·Phase: NA
-
Occipital Transcutaneous Stimulation in Chronic Migraine
NCT02307071 ·Status: UNKNOWN ·Phase: PHASE4
-
A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH)
NCT05064397 ·Status: COMPLETED ·Phase: PHASE3
-
Neurostimulation Device for Treatment of Migraine Headache
NCT01630044 ·Status: COMPLETED ·Phase: NA
-
A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
NCT02797951 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Characteristics and Pathophysiology of Post-Traumatic Headache
NCT03791515 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Erenumab in Chronic Cluster Headache
NCT04970355 ·Status: COMPLETED ·Phase: PHASE2
-
Physiological Changes With SPG Stimulation in Migraine Patients
NCT02510742 ·Status: COMPLETED ·Phase: NA
-
Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
NCT07159750 ·Status: RECRUITING
-
A Study of Galcanezumab in Participants With Chronic Cluster Headache
NCT02438826 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients
NCT04452929 ·Status: UNKNOWN ·Phase: NA
-
Refractory Chronic Cluster Headache: Exploring the Potential of Repetitive Transcranial Magnetic Stimulation
NCT06917144 ·Status: COMPLETED ·Phase: NA
-
The Efficacy and Safety of Sphenopalatine Ganglion Pulsed Radiofrequency Treatment for Cluster Headache
NCT03567590 ·Status: COMPLETED ·Phase: NA
-
A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster Headache
NCT03107052 ·Status: TERMINATED ·Phase: PHASE3
-
A Close Examination of Patient Experiences in Cluster Headache Clinical Research
NCT05978258 ·Status: NOT_YET_RECRUITING
-
Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With Erenumab
NCT04592952 ·Status: UNKNOWN ·Phase: PHASE4
-
Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.
NCT00358839 ·Status: COMPLETED ·Phase: NA
-
Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster Headache
NCT03944876 ·Status: RECRUITING ·Phase: PHASE3
-
A Feasibility Clinical Trial to Evaluate High Frequency Spinal Cord Stimulation for the Treatment of Patients With Chronic Migraine
NCT01653340 ·Status: COMPLETED ·Phase: NA
-
Electrical Stimulation of the Sphenopalatine Ganglion for the Treatment of Migraine Headaches
NCT01294046 ·Status: COMPLETED ·Phase: NA
-
Prevention and Acute Treatment of Chronic Cluster Headache Compared to Standard of Care
NCT01701245 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Of Galcanezumab In Participants With Episodic Cluster Headache
NCT02397473 ·Status: COMPLETED ·Phase: PHASE3